Search research articles
Contact Us
Filters
Showing results (1-10 of 232) with videos related to
Page
of 24
Sort By:
The Oncologist
|
November 8, 2005
Provocative optimism in the treatment of early stage disease
Norman Wolmark
The New England Journal of Medicine
|
October 11, 2003
Letrozole after tamoxifen for breast cancer--what is the price of success?
John Bryant, Norman Wolmark
The New England Journal of Medicine
|
March 28, 2008
HER2 status and benefit from adjuvant trastuzumab in breast cancer
Soonmyung Paik, Chungyeul Kim, Norman Wolmark
American Journal of Surgery
|
October 18, 2002
Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer
Thomas B Julian, Deborah Dusi, Norman Wolmark
The New England Journal of Medicine
|
December 3, 2010
Amenorrhea from breast cancer therapy--not a matter of dose
Sandra M Swain, Jong-Hyeon Jeong, Norman Wolmark
Seminars in Oncology
|
December 3, 2014
NRG Oncology research opportunities within the new National Clinical Trials Network
Walter J Curran, Philip J DiSaia, Norman Wolmark
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2005
Update on design of the National Surgical Adjuvant Breast and Bowel Project trial R-04
Michael J O'Connell, Norman Wolmark, Robert Beart, et al.
Journal of the National Cancer Institute
|
December 17, 2004
Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials
Bernard Fisher, Jong-Hyeon Jeong, Stewart Anderson, et al.
Diseases of the Colon and Rectum
|
August 9, 2003
Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01
Edwin R Fisher, Linda Colangelo, Samuel Wieand, et al.
Cancer Investigation
|
September 18, 2008
FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer
Saima Sharif, Michael J O'Connell, Greg Yothers, et al.
Page
of 24
Search research articles
Search
Showing results (1-10 of 232) with videos related to
Sort By:
Page
of 24
The Oncologist
|
November 8, 2005
Provocative optimism in the treatment of early stage disease
Norman Wolmark
The New England Journal of Medicine
|
October 11, 2003
Letrozole after tamoxifen for breast cancer--what is the price of success?
John Bryant, Norman Wolmark
The New England Journal of Medicine
|
March 28, 2008
HER2 status and benefit from adjuvant trastuzumab in breast cancer
Soonmyung Paik, Chungyeul Kim, Norman Wolmark
American Journal of Surgery
|
October 18, 2002
Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer
Thomas B Julian, Deborah Dusi, Norman Wolmark
The New England Journal of Medicine
|
December 3, 2010
Amenorrhea from breast cancer therapy--not a matter of dose
Sandra M Swain, Jong-Hyeon Jeong, Norman Wolmark
Seminars in Oncology
|
December 3, 2014
NRG Oncology research opportunities within the new National Clinical Trials Network
Walter J Curran, Philip J DiSaia, Norman Wolmark
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2005
Update on design of the National Surgical Adjuvant Breast and Bowel Project trial R-04
Michael J O'Connell, Norman Wolmark, Robert Beart, et al.
Journal of the National Cancer Institute
|
December 17, 2004
Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials
Bernard Fisher, Jong-Hyeon Jeong, Stewart Anderson, et al.
Diseases of the Colon and Rectum
|
August 9, 2003
Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01
Edwin R Fisher, Linda Colangelo, Samuel Wieand, et al.
Cancer Investigation
|
September 18, 2008
FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer
Saima Sharif, Michael J O'Connell, Greg Yothers, et al.
Page
of 24